Retatrutide 10mg

Timing: Morning, fasted    Frequency: Once weekly, same day each week    Duration: Run in 8–12 week blocks, assess and continue

A triple-receptor agonist under active research for metabolic and endocrine applications, activating GLP-1, GIP, and glucagon pathways concurrently. The 10mg vial is a smaller-format option for early titration phases or lower research dose ranges than the 20mg vial.

Notes: Begin at the low end and titrate upward across weeks to manage tolerability. Pairs with the established appetite and metabolic-activity timeline.